The hypertension medication nilvadipine, a dihydropyridine calcium channel blocker, did not slow cognitive decline in patients with mild to moderate Alzheimer disease (AD), found a study published in PLOS Medicine. In a previous small study of patients with hypertension and mild cognitive impairment, nilvadipine stabilized cognitive decline.
Slomski A. Hypertension Drug Fails to Slow Cognitive Decline. JAMA. 2018;320(20):2068. doi:10.1001/jama.2018.18513
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: